New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent ...

Initial clinical observations suggest high level of T cells reprogramming and CAR-T expansion at the starting dose without lymphodepletion At 28 ...

Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its new ProPak™ GMP cytokines, alongside its portfolio of innovative products and solutions supporting cell and gene therapy ...

NSW Health advises HMPV is prone to resolving within one to 10 days of infection. Unlike Covid, the average person is likely ...

Neither coffee drinking pattern was tied to more or less cancer-specific mortality.

In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle ...

Successfully dosed 6 patients in safety run-in segment, now accelerating enrollmentPositive data from first four patients announced December 2024NXC-201 is the only one-time CAR-T therapy in developme ...

NXC-201 is a sterically-optimized BCMA-targeted chimeric antigen receptor T (CAR-T) cell therapy. Initial data from Phase 1b/2 ex-U.S. study NEXICART-1 has demonstrated high complete response rates ...

A pioneering study has uncovered the complex and dual roles of neutrophils in cancer development, demonstrating their ...

TOPLINE: Sjögren disease (SjD) presents three distinct phenotypes ― B-cell active with low symptom burden, high systemic ...

Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Familiar with the powerful influence of the gut–brain axis, Maraganore and his team set out to investigate how the ...